Phytonix
Phytonix is an industrial biotechnology company that uses engineered cyanobacteria and photosynthesis to convert industrial CO2 emissions directly into biobutanol, pentanol, and other higher alcohols, licensing its platform to industrial partners and targeting chemical producers and CO2 emitters.
- Company typePrivate
- Founded2009
- HeadquartersAsheville, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Phytonix does
Phytonix is an industrial biotechnology company that uses synthetic biology combined with photosynthesis to engineer cyanobacteria that convert industrial carbon dioxide emissions directly into sustainable industrial chemicals, primarily biobutanol (n-butanol), pentanol, and other C4-C8 higher alcohols. Its patented platform relies on organisms that directly synthesize and secrete target chemicals, bypassing biomass harvesting, collection, transportation, and downstream refinement, and emits oxygen as a byproduct while consuming CO2 as the sole carbon feedstock. The company also holds what it describes as a first-of-its-kind biosafety-guarded technology using redundant mechanisms to prevent engineered organisms from surviving or reproducing outside the production environment, and was the first firm to submit a Microbial Commercial Activity Notice (MCAN) for industrial use of genetically modified cyanobacteria in the United States.
The company serves industrial CO2 emitters (power utilities, factories, manufacturing facilities) and the broader chemical industry seeking biobased, carbon-negative alternatives to petroleum-derived industrial chemicals, with a stated target market approaching USD $10 billion for n-butanol and ~$50 billion for higher alcohols globally. It also extends into specialty chemicals such as fragrance ingredients through a partnership with Genome British Columbia under the CleanBC Initiative.
Phytonix operates a capital-light, distributed business model: it licenses its patented processes and proprietary technologies to strategic industrial partners, runs development laboratories at Uppsala University's Angstrom Laboratory in Sweden and at the National Research Council of Canada's Marine Research Station in Nova Scotia, and is conducting indoor pilot testing with planned outdoor pilot deployment alongside two multinational corporate partners (a large European power utility and a large US industrial manufacturer). Revenue mechanics are expected to combine technology licensing royalties, sales of photosynthetically produced chemicals, and CO2 mitigation services, though the company has not yet disclosed commercial-scale revenue. The firm is privately held, headquartered in Black Mountain, North Carolina, with a wholly owned Canadian subsidiary in Vancouver, British Columbia.
Phytonix firmographics
Firmographics- Name
- Phytonix
- Legal name
- Phytonix Corporation
- Website
- https://phytonix.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Phytonix is an industrial biotechnology company that uses engineered cyanobacteria and photosynthesis to convert industrial CO2 emissions directly into biobutanol, pentanol, and other higher alcohols, licensing its platform to industrial partners and targeting chemical producers and CO2 emitters.
- Ownership category
- akta.pro rank
Phytonix industry classification
Industry- Product category
- Industrial Biotechnology – Sustainable Chemicals
- NAICS
- Basic Chemical Manufacturing (3251)
- SIC
- Industrial Organic Chemicals (2860)
- akta.pro primary industry
- Biological CO₂ Utilization (algae/biotech conversion to fuels, chemicals, proteins) (EUABAIAJ)
- akta.pro secondary industries
- Bio-based Solvents & Process Chemicals (e.g., bio-acetone, bio-butanol, bio-IPA, green solvents) (EUAAAIAB), Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol) (EUAAAIAA)
Keywords
Where Phytonix is headquartered
LocationHeadquarters
- HQ city
- Asheville
- HQ country
- United States
- HQ region
- North America
Offices5 records
Markets served
Phytonix business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Technology or R&D, Personnel
Revenue model
- Technology Licensing: Phytonix seeks to be a leading provider and licensor of technologies and proprietary processes for the photosynthetic production of chemicals directly from CO2 feedstock. Revenue streams come from licensing their patented technologies and processes to industrial partners.
- Photosynthetically-based Industrial Chemical Production: Production and sale of sustainable industrial chemicals including biobutanol, pentanol, and other higher alcohols produced directly from carbon dioxide emissions.
- CO2 Mitigation Services: Conversion of industrial CO2 emissions into solar chemicals, providing carbon mitigation services to industrial emitters.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
Phytonix product offering
Product offeringCore offering
Phytonix uses synthetic biology combined with photosynthesis to engineer cyanobacteria that directly synthesize and secrete sustainable industrial chemicals—primarily biobutanol (n-butanol), pentanol, and other higher alcohols—using carbon dioxide as the sole feedstock. The process bypasses biomass production, collection, transportation, and downstream refinement, and emits oxygen as a byproduct, enabling carbon-negative chemical production at lower cost than incumbent fossil-based producers.
Product overview
Phytonix is an industrial biotechnology company that operates a unified photosynthetic chemical production platform. The core technology uses engineered cyanobacteria (photosynthetic bacteria) to convert industrial carbon dioxide emissions directly into sustainable industrial chemicals and fuels through synthetic biology. The primary products include biobutanol (n-butanol), pentanol, and other higher alcohols. The platform relies on patented and patent-pending technologies including engineered bacteria that directly secrete biobutanol and biosafety-guarded technology with redundant mechanisms to prevent organism survival outside production environments. The company offers its technologies through licensing arrangements and collaborative partnerships, with production facilities designed to be co-located with industrial CO2 emitters.
Differentiator
Problem solved
Functional benefit
Products and services
- Biobutanol (n-butanol)
Quantifiable outcome
- Directly reduces greenhouse gas emissions at 1 metric tonne of CO2 per 138 gallons of biobutanol produced
- +4 more outcomes
Companies that use Phytonix
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Phytonix technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Phytonix partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core.
- Genome British ColumbiacoreNon-profit Genome British Columbia and Phytonix Corporation announced a partnership to create a manufacturing platform where CO2 emissions from industrial facilities will be converted into specialty chemicals for use in the fragrance industry. This partnership aligns with the CleanBC Initiative and positions Phytonix in the cosmetics and specialty chemicals markets.
- Large European Power Utility and Energy CompanycoreOne of two multinational corporate strategic partners working with Phytonix to deploy carbon dioxide utilization (CDU) technology to capture their waste CO2 emissions and convert them to low cost solar chemicals and fuels. This is a pilot scale installation with planned rapid expansion to commercial scale.
- Large US Industrial Manufacturing Company (Southeastern USA)coreOne of two multinational corporate strategic partners working with Phytonix for pilot scale installations with planned expansion to commercial scale. The partnership involves deploying CDU technology to capture waste CO2 emissions and convert them to sustainable chemicals.
- Uppsala University (Angstrom Laboratory)coreDr. Peter Lindblad serves as Project Leader for Butanol Organism Development. His research group at Angstrom Laboratory focuses on renewable solar fuel production via engineered cyanobacterial microbial cell factories, including development of liquid transportation fuels and microbial-based H2-production. This is part of the Swedish Energy Agency program on Natural and Artificial Photosynthesis.
- National Research Council of Canada (NRC)coreDr. Patrick J. McGinn serves as Team Lead for Indoor Pilot Testing and Process Development at the NRC Marine Research Station in Ketch Harbour, Nova Scotia, Canada. The NRC facility houses butanol-producing cyanobacteria cultures and butanol vapor recovery technology.
- Phytonix Canada CorporationcoreWholly owned subsidiary of Phytonix Corporation based in Vancouver, BC, Canada. Serves as the corporate entity for Canadian operations and partnerships.
Scale indicators7 records
Recent moves7 records
Expansion highlights6 records
Phytonix competitors and assessment
Company assessmentDirect peers
- C-Zero: C-Zero develops technology to decarbonize natural gas and produce hydrogen/chemicals from natural gas with CO2 as a byproduct, pursuing the CO2-to-chemicals theme. C-Zero represents an emerging-direct competitor in the carbon-to-value value chain alongside Phytonix.
- Joule Unlimited: Joule Unlimited developed engineered photosynthetic organisms (cyanobacteria and algae) for direct conversion of CO2 and sunlight to fuels and chemicals. Both companies explored the photobiological production of fuels/chemicals at industrial scale via engineered microbes.
- Kiverdi: Kiverdi uses engineered microorganisms to convert CO2 into oils, proteins, and specialty chemicals, including palm oil alternatives. Both Phytonix and Kiverdi target the CO2-to-chemicals opportunity using synthetic biology platforms.
- Algenol Biotech: Algenol engineered cyanobacteria to convert CO2 into ethanol and other hydrocarbons under sunlight, the closest architectural analog to Phytonix's photosynthesis-driven cyanobacterial platform. Both compete on using cyanobacteria as the chassis organism for CO2-to-chemicals production.
- Prometheus Fuels: Prometheus Fuels produces gasoline and jet fuel directly from atmospheric CO2 using renewable electricity-driven processes, targeting the same CO2-as-feedstock end market Phytonix addresses with photosynthesis-driven alcohols. Both convert CO2 to drop-in industrial chemicals/fuels.
- Newlight Technologies (AirCarbon): Newlight commercializes a similar concept using microorganisms to convert greenhouse gases (methane/CO2) into polyhydroxyalkanoate (PHA) bioplastics. Both companies are industrial biotech players turning captured carbon into market-ready chemicals via engineered microbes.
- LanzaTech: LanzaTech is the most direct peer: it uses engineered acetogens to convert industrial waste gases (CO, CO2) into fuels and chemicals such as ethanol and butanol. Both companies pursue the CO2/waste-gas-to-chemicals thesis via engineered microbes, with licensing and offtake partnerships as the commercialization path.
Broad incumbents
- Synthetic Genomics: Synthetic Genomics (now part of the Viridos vehicle) was a leading synbio company commercializing engineered algae for fuels/chemicals and has previously pursued similar CO2-utilization programs. It is a broader, more established synbio platform competitor with overlapping photobiological-to-chemicals ambitions.
- BASF: BASF is the global incumbent petrochemical leader, including a major n-butanol business that is being targeted by Phytonix's CO2-derived biobutanol. BASF's incumbent scale, distribution, and customer relationships are the primary incumbent baseline that Phytonix is positioning to disrupt on cost and sustainability.
Emerging players
- Aemetis: Aemetis is a renewable fuels and biochemicals company producing cellulosic ethanol and renewable diesel/gasoline from low-carbon feedstocks. It is an adjacent emerging player in biobased industrial chemicals and renewable fuels competing for similar low-carbon value pools.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Phytonix social profiles
Digital presencePhytonix financial estimates
Financial estimateRevenue estimate
Valuation estimate
Phytonix leadership team
Management profileNumber of profiles
Profiles5 records
Phytonix subsidiaries and ownership
Company hierarchySubsidiaries1 record
Phytonix funding detail
Funding detailFunding overview
Funding rounds6 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Phytonix M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Phytonix
What does Phytonix do?
Phytonix uses synthetic biology combined with photosynthesis to engineer cyanobacteria that directly synthesize and secrete sustainable industrial chemicals—primarily biobutanol (n-butanol), pentanol, and other higher alcohols—using carbon dioxide as the sole feedstock. The process bypasses biomass production, collection, transportation, and downstream refinement, and emits oxygen as a byproduct, enabling carbon-negative chemical production at lower cost than incumbent fossil-based producers.
Is Phytonix a public or private company?
Phytonix is a private company. It is classified as venture growth investor backed and is currently operating.
When was Phytonix founded?
Phytonix was founded in 2009. It employs 1 to 10 people.
Where is Phytonix based?
Phytonix is headquartered in Asheville, United States, in the North America region.
How does Phytonix make money?
Three revenue lines are on record. Technology Licensing is the primary driver. The others are photosynthetically-based Industrial Chemical Production and CO2 Mitigation Services.
Who are Phytonix's main competitors?
Direct peers on record are C-Zero, Joule Unlimited, Kiverdi, Algenol Biotech, Prometheus Fuels, Newlight Technologies (AirCarbon) and LanzaTech. Broad incumbents are Synthetic Genomics and BASF. Aemetis is listed as an emerging player.
Does Phytonix have an API?
No public API is recorded for Phytonix.
What industry is Phytonix in?
Phytonix's product category is Industrial Biotechnology – Sustainable Chemicals. Its primary akta.pro industry code is EUABAIAJ, Biological CO₂ Utilization (algae/biotech conversion to fuels, chemicals, proteins), with a secondary code of EUAAAIAB, Bio-based Solvents & Process Chemicals (e.g., bio-acetone, bio-butanol, bio-IPA, green solvents). Its NAICS code is 3251 and its SIC code is 2860.